TY - JOUR
T1 - Language impairment in the genetic forms of behavioural variant frontotemporal dementia
AU - Samra, Kiran
AU - MacDougall, Amy M.
AU - Genetic Frontotemporal Initiative (GENFI)
AU - Bouzigues, Arabella
AU - Bocchetta, Martina
AU - Cash, David M.
AU - Greaves, Caroline V.
AU - Convery, Rhian S.
AU - van Swieten, John C.
AU - Seelaar, Harro
AU - Jiskoot, Lize
AU - Moreno, Fermin
AU - Sanchez-Valle, Raquel
AU - Laforce, Robert
AU - Graff, Caroline
AU - Masellis, Mario
AU - Tartaglia, Maria Carmela
AU - Rowe, James B.
AU - Borroni, Barbara
AU - Finger, Elizabeth
AU - Synofzik, Matthis
AU - Galimberti, Daniela
AU - Vandenberghe, Rik
AU - de Mendonça, Alexandre
AU - Butler, Christopher R.
AU - Gerhard, Alexander
AU - Ducharme, Simon
AU - Le Ber, Isabelle
AU - Tiraboschi, Pietro
AU - Santana, Isabel
AU - Pasquier, Florence
AU - Levin, Johannes
AU - Otto, Markus
AU - Sorbi, Sandro
AU - Rohrer, Jonathan D.
AU - Russell, Lucy L.
AU - Nelson, Annabel
AU - Thomas, David L.
AU - Todd, Emily
AU - Benotmane, Hanya
AU - Nicholas, Jennifer
AU - Shafei, Rachelle
AU - Timberlake, Carolyn
AU - Cope, Thomas
AU - Rittman, Timothy
AU - Benussi, Alberto
AU - Premi, Enrico
AU - Poos, Jackie
AU - Papma, Janne M.
AU - Giannini, Lucia
AU - van Minkelen, Rick
N1 - Publisher Copyright: © 2022, The Author(s).
PY - 2023/4
Y1 - 2023/4
N2 - Background: Behavioural variant fronto-temporal dementia (bvFTD) is characterised by a progressive change in personality in association with atrophy of the frontal and temporal lobes. Whilst language impairment has been described in people with bvFTD, little is currently known about the extent or type of linguistic difficulties that occur, particularly in the genetic forms. Methods: Participants with genetic bvFTD along with healthy controls were recruited from the international multicentre Genetic FTD Initiative (GENFI). Linguistic symptoms were assessed using items from the Progressive Aphasia Severity Scale (PASS). Additionally, participants undertook the Boston Naming Test (BNT), modified Camel and Cactus Test (mCCT) and a category fluency test. Participants underwent a 3T volumetric T1-weighted MRI, with language network regional brain volumes measured and compared between the genetic groups and controls. Results: 76% of the genetic bvFTD cohort had impairment in at least one language symptom: 83% C9orf72, 80% MAPT and 56% GRN mutation carriers. All three genetic groups had significantly impaired functional communication, decreased fluency, and impaired sentence comprehension. C9orf72 mutation carriers also had significantly impaired articulation and word retrieval as well as dysgraphia whilst the MAPT mutation group also had impaired word retrieval and single word comprehension. All three groups had difficulties with naming, semantic knowledge and verbal fluency. Atrophy in key left perisylvian language regions differed between the groups, with generalised involvement in the C9orf72 group and more focal temporal and insula involvement in the other groups. Correlates of language symptoms and test scores also differed between the groups. Conclusions: Language deficits exist in a substantial proportion of people with familial bvFTD across all three genetic groups. Significant atrophy is seen in the dominant perisylvian language areas and correlates with language impairments within each of the genetic groups. Improved understanding of the language phenotype in the main genetic bvFTD subtypes will be helpful in future studies, particularly in clinical trials where accurate stratification and monitoring of disease progression is required.
AB - Background: Behavioural variant fronto-temporal dementia (bvFTD) is characterised by a progressive change in personality in association with atrophy of the frontal and temporal lobes. Whilst language impairment has been described in people with bvFTD, little is currently known about the extent or type of linguistic difficulties that occur, particularly in the genetic forms. Methods: Participants with genetic bvFTD along with healthy controls were recruited from the international multicentre Genetic FTD Initiative (GENFI). Linguistic symptoms were assessed using items from the Progressive Aphasia Severity Scale (PASS). Additionally, participants undertook the Boston Naming Test (BNT), modified Camel and Cactus Test (mCCT) and a category fluency test. Participants underwent a 3T volumetric T1-weighted MRI, with language network regional brain volumes measured and compared between the genetic groups and controls. Results: 76% of the genetic bvFTD cohort had impairment in at least one language symptom: 83% C9orf72, 80% MAPT and 56% GRN mutation carriers. All three genetic groups had significantly impaired functional communication, decreased fluency, and impaired sentence comprehension. C9orf72 mutation carriers also had significantly impaired articulation and word retrieval as well as dysgraphia whilst the MAPT mutation group also had impaired word retrieval and single word comprehension. All three groups had difficulties with naming, semantic knowledge and verbal fluency. Atrophy in key left perisylvian language regions differed between the groups, with generalised involvement in the C9orf72 group and more focal temporal and insula involvement in the other groups. Correlates of language symptoms and test scores also differed between the groups. Conclusions: Language deficits exist in a substantial proportion of people with familial bvFTD across all three genetic groups. Significant atrophy is seen in the dominant perisylvian language areas and correlates with language impairments within each of the genetic groups. Improved understanding of the language phenotype in the main genetic bvFTD subtypes will be helpful in future studies, particularly in clinical trials where accurate stratification and monitoring of disease progression is required.
UR - http://www.scopus.com/inward/record.url?scp=85150489497&partnerID=8YFLogxK
U2 - 10.1007/s00415-022-11512-1
DO - 10.1007/s00415-022-11512-1
M3 - Article
C2 - 36538154
AN - SCOPUS:85150489497
SN - 0340-5354
VL - 270
SP - 1976
EP - 1988
JO - Journal of Neurology
JF - Journal of Neurology
IS - 4
ER -